MTMurat Emre Tokur

Murat Emre Tokur

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Murat Emre Tokur has a total of 158 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Epidemiology and its results in hip fractures followed in postoperative intensive care

    by Emel Yildiz, Murat Emre Tokur, Özlem Arik, Ayşe Yildirimer, Halil Ibrahim Yildiz, Canan Balci

    The global proportion of individuals aged ≥ 65 years is approximately 9%, and hip fractures (HFx) represent one of the most common and serious injuries in this population. This study retrospectively evaluated postoperative intensive care unit (ICU) admissions among patients with HFx, focusing on 30-day, 90-day, and 1-year mortality outcomes. This retrospective study included patients with HFx who were admitted to the ICU after surgery. Collected data included demographic characteristics (age and gender), admission diagnosis, comorbidities, ICU length of stay (LOS), Acute Physiology and Chronic Health Evaluation (APACHE) II scores, American Society of Anesthesiologists score, LOS, 30-day/ 90-day/1-year mortality, day of surgery, and the type anesthesia used. The mortality rate were 34.4% at 30-days 41.3% at 90 days and 24.1% at 1 years after surgery. Patients who died had significantly higher mean age, Acute Physiology and Chronic Health Evaluation II scores, ICU LOS, and total hospital stay. Our findings suggest that postoperative ICU admission criteria for patients with HFx should be reconsidered. The results also emphasize the importance of optimizing ICU LOS in this patient group. Further prospective studies are needed to clarify whether prolonged ICU stay contributes to increased mortality or reflects greater baseline severity.

  • Ultrasound Assessment of End-Expiratory Diaphragm Thickness Across Recumbent Positions: Implications for Measurement Standardization

    by Ugur Verep, Seher Ozyurek, Umut Ziya Kocak, Murat Emre Tokur, Ugur Koca, Ali Necati Gokmen, Nihal Gelecek

    Background: Ultrasound-based diaphragm thickness assessment is increasingly used in respiratory and rehabilitation settings. However, measurements may be influenced by body position, potentially confounding clinical interpretation. Objective: To investigate whether common recumbent positions (supine, prone, side-lying) alter end-expiratory right hemidiaphragm thickness at the end of quiet expiration in healthy young men. Methods: In this randomized-order, within-subject cross-sectional study, 41 healthy male participants (18–24 years) underwent B-mode ultrasound assessment of right hemidiaphragm thickness at the zone of apposition during end-expiration. Three measurements per position were averaged. Differences across positions were analyzed using the Friedman test. Results: Diaphragm thickness differed significantly across positions ( p < 0.001), with greatest values observed in prone, followed by side-lying and supine positions. Conclusion: End-expiratory diaphragm thickness is posture-dependent in healthy young men. These findings demonstrate that diaphragm thickness measurements are strongly posture-dependent and highlight the necessity of strict positioning standardization for reliable ultrasound-based clinical assessment.

  • Open Access

    A case of thoracic aortic thrombosis in a patient with COVID-19 pneumonia

    by Kutlay Aydın, Murat Emre Tokur

    Patients infected with the 2019 novel coronavirus (COVID-19) predominantly present with respiratory symptoms. In severe cases, COVID-19 creates a prothrombotic state that significantly increases the risk of thromboembolic events. These complications are primarily in the form of venous thromboembolism, with a cumulative incidence of up to 49% among hospitalized patients. In contrast, arterial thromboembolic events such as ischemic stroke and myocardial infarction have been rarely reported in the literature. In this case report, we present a case of aortic thrombosis complicated by peripheral embolism and/or thrombosis as an example of arterial thromboembolism.

  • Open Access

    COVID-19 yoğun bakımda takip edilen ARDS hastalarında iki farklı deksametazon dozunun hiperinflamasyon üzerine etkinliğinin retrospektif olarak değerlendirilmesi

    by Merve Yaman, Murat Emre Tokur, Canan Balcı

    Giriş ve Amaç: Yoğun bakımda COVID-19 ile takip edilen ARDS hastalarında kullanılan iki farklı deksametazon tedavi protokolünün klinik ve laboratuvar sonuçlarını retrospektif olarak karşılaştırmak. Yöntem ve Gereçler: Pandemi Yoğun Bakım Üniteleri’nde deksametazon tedavisi başlanmış hastalar iki gruba ayrıldı. Grup 1: 6 mg/gün deksametazon tedavisi alanlar (n=41), Grup 2: 0-5 gün 20 mg/gün ve 6-10 gün 10 mg/gün deksametazon tedavisi alanlar (n=39). 0. günden 10. güne gruplar arası klinik sonuçlar ve laboratuvar değerlerin değişimleri karşılaştırıldı. Bulgular: 20 mg deksametazon verilen hastalarda 0. gün APACHE II skorları anlamlı düzeyde yüksek tespit edildi (p: 0,039). Hastaların yoğun bakımdaki on günlük deksametazon tedavisi sonrasında 0. ve 10. gün parametre değişimleri incelendiğinde; 20 mg grubunda prokalsitonin ve D-Dimer değerlerinin istatistiksel olarak anlamlı bir artış gösterdiği belirlendi (sırasıyla p: 0.038 ve p: 0.025). Son olarak deksametazon tedavisinin mortalite üzerindeki etkisi incelendi ve gruplar arasında fark saptanmadı. Tartışma ve Sonuç: COVID-19 yoğun bakım ünitelerindeki ARDS hastalarında, deksametazon tedavisiyle ilgili literatürde mortalite karşılaştırmaları yapılmıştır. Bizlerse çalışmamızda farklı olarak mortaliteyle birlikte laboratuvar parametreleri açısından karşılaştırma yaptık. Sonuç olarak; deksametazon tedavisinin klinik ve laboratuvar parametreleri iyileştirdiği fakat fayda/zarar oranı ve yan etkileri açısından bakıldığında; viral solunum yolu enfeksiyonlarında oksijen tedavisi ihtiyacı olan olgularda 6 mg dozunun, hiperinflamasyonun ön planda olduğu şiddetli olgularda ise 20 mg dozunun güvenle kullanılabileceğini düşünmekteyiz.

  • Open Access

    Evaluation of Patients with COVID-19 Followed Up in Intensive Care Units in the Second Year of the Pandemic: A Multicenter Point Prevalence Study

    by Sinem Güngör, Özlem Ediboğlu, Özlem Yazıcıoğlu Moçin, Nalan Adıgüzel, Eylem Tuncay, İnşa Gül Ekiz İşcanlı, Berrin Er, Zuhal Karakurt, Sema Turan, Behiye Deniz Kosovalı, et al.

    COVID-19,intensive care,intensive care unit,pandemic,follow-up


  • Bibliometric Analysis of Scientific Output Growth in the Field of Lung Transplantation

    by Murat Emre Tokur, Sevil Alkan

    Background Lung transplantation (LT) has recently emerged as a scientifically validated curative therapeutic modality for patients afflicted with end-stage lung disease. This study aimed to conduct a global bibliometric analysis of research articles on LT between 1983 and 2021. Methods Employing the Web of Science database, a bibliometric analysis was conducted to assess the expansion of scientific output within the field of LT. We searched specific bibliometric characteristics such as language, and year of publication, first author, institutional affiliation, main publishing journals, and highly cited articles. Additionally, we made comparisons of the most productive countries. The VOSviewer program and the open-source visualization software Biblioshiny (version 2.0) were used to perform the bibliometric analysis. Results We identified 10,467 articles on LT published between 1983 and 2021, of which 94.898% were published in the Science Citation Index Expanded. The articles were from 101 different research areas. The publications were from 81 different countries globally, and mostly from the United States (41.196%), Germany (7.118%), and Canada (6.372%). The Journal of Heart and Lung Transplantation was the most published journal. Four thousand seven hundred and ninety three of the publications were published in the last 10 years with a 78,781 citation number in total. The highest number of publications and citations was in 2021. Conclusion The majority of cutting-edge research findings are focused on only a few developed nations, and exchanges with emerging nations are still in their infancy. The United States has a strong, commanding position among the active countries in LT.


  • Open Access

    Bibliometric and Visual Analysis of Palliative Nutrition Research Based on Web of Science

    by Sevil Alkan, Murat Emre Tokur

    Objective: Nutritional therapy has been shown to reduce the mortality rates of critically ill individuals. In recent years, there has been a significant increase in scholarly curiosity about the growing use of palliative nutrition. In order to determine the global research output on palliative nutrition, this bibliometric analysis was conducted to assess the current status of research trends and research directions. Methods: The bibliometric data of the study was obtained from the online database Web of Science and analyzed and visualized with Excel, the Bibliometrix R package (version 4.1.2), and the bibliometric online application (https://bibliometric.com/app) tools. Results: A total of 1067 publications were included in this study. The majority of publications (398,37.30%) and citations (n: 9252) in this discipline have come from the United States. The most frequent publication type detected was article (n: 794). Publications published in 398 different sources (journals/books etc.). The international co-authorship rate was 11.62%. In the last 20 years, the annual number of publications has drastically expanded. The highest number of publications was published in 2020 and 2021 (n: 67, and n: 64 respectively). Australia, France, Canada, Japan, and China stand out as the countries with the highest number of publications in recent years. The terms 'end, care, hydration, nutrition, life, decision-making, artificial nutrition, and palliative care' were the most preferred keywords. Conclusion: Finally, given the number of palliative care patients globally is expected to rise, it is critical to do ongoing research on appropriate nutritional therapy for these patients. As our study shows study gaps and study trends, it can provide insight for future work in this field.


  • Open Access

    Mortality predictors on the day of healthcare-associated Acinetobacter baumanni bacteremia in intensive care unit

    by Murat Emre Tokur, Pervin Korkmaz, Sevil Alkan, Emel Yıldız, Özlem Arık, Duygu Perçin Renders, Canan Balcı

    Introduction: Mortality of healthcare-associated Acinetobacter baumannii bacteremia can be 50-60% in intensive care units (ICUs). We aimed to determine the risk factors for 28-day mortality in patients with sepsis due to A. baumannii bacteremia during their ICU follow-up. Methodology: Demographic characteristics, disease severity scores on admission and bacteremia day (BD), resistance status, invasive interventions, and laboratory values showing the infection and severity of the BD, were compared between groups with and without mortality as a retrospective cohort study in the ICU of a tertiary hospital. Results: Of a total of 2411 patients, there were 192 cases of bacteremia. After applying the exclusion criteria, 39 patients were recruited for the study, 25 of whom died (mortality rate 64.1%). Higher age, Simplified Acute Physiology Score II (SAPS II) on admission and high Sequential Organ Failure Assessment Score (SOFA), Red Blood Cell Distribution Width (RDW) (p < 0.001), and C-Reactive Protein (CRP) (p = 0.002) on the BD and invasive intervention in follow-up were associated with mortality. When CRP and RDW were both positive, sensitivity was 72%, specificity was 100%, negative predictive value was 33%, and positive predictive value was 100% for the 28-day mortality after BD. Based on multivariate analysis, CRP and RDW values on the BD were independent risk factors for mortality. Conclusions: It is critical to monitor SOFA, RDW, and CRP values in older ICU patients with SAPS II scores and who undergo invasive intervention in follow-up. Increases in these parameters may indicate bacteremia with high mortality due to A. baumannii.


  • Open Access

    Global network analysis on COVID-19 related acute respiratory distress syndrome

    by Sevil Alkan Çeviker, Murat Emre Tokur, Alper Tahmaz, Mustafa Yılmaz, Cemile Uyar

    Objectives: This study aims to examine the studies on COVID-related ARDS globally. Materials and methods: The Web of Science (WoS) database was scanned to search for publications until December 31, 2020. Results were analyzed to present various bibliometric indicators, the maps were visualized using the VOSviewer program (VOSviewer). The Hirsch (h-index) index and impact factor (IF) of the publishing journals were used as indicators of the impact of the publications. The publications containing the keywords “COVID-19” or “SARS-CoV-2” and “acute respiratory distress syndrome” or “ARDS” were examined. Results: A total 113 articles were evaluated. The average number of citations was found to be 26.97. The majority of the publications were from the USA (29.20%). Most cited articles were published in the European Respiratory Journal and Frontiers in Medicine journals, but most of the publications were from Critical Care and Cureus journals. Conclusion: With the spread of the pandemic, bibliometric analysis should be used more widely in order to evaluate the quality of the increasing academic paper and to guide the missing study issues.

  • İntraoperatif Aspirasyon ve Perioperatif Aspirasyon Pnömonisi Tedavisi

    by Murat Emre Tokur

    İntraoperatif aspirasyon, genel anestezi sırasında gastrik içeriğin akciğerlere kaçmasıyla karakterize, her 2000 vakadan birinde görülebilen ve yüksek morbidite riski taşıyan kritik bir durumdur. Tanı; ani hipoksi, taşikardi, havayolu basınçlarında artış veya gastrik içeriğin doğrudan görülmesiyle konur. Müdahalede hastanın Trendelenburg pozisyonuna getirilmesi ve hızla havayolu temizliğinin yapılması esastır. Risk faktörleri arasında obezite, acil cerrahi ve preoperatif açlık süresine uyulmaması öne çıkarken; önlemede ASA açlık kılavuzlarına uyum ve hızlı sıralı indüksiyon (HSİ) kritik rol oynar. Aspirasyon sonrası gelişen aspirasyon pnömonisi, orofaringeal veya gastrik içeriğin akciğerlerde enfeksiyon oluşturmasıdır. Tedavi, enfeksiyonun geliştiği yere (toplum veya hastane) ve hastanın risk faktörlerine göre belirlenen ampirik antibiyoterapiyi içerir. Son 90 gün içinde intravenöz antibiyotik kullanımı, MRSA ve Pseudomonas gibi dirençli patojenler için en önemli risk faktörüdür. Şiddetli vakalarda yoğun bakım takibi, akciğer koruyucu ventilasyon veya ECMO desteği gerekebilir. Prognoz, erken tanı, uygun antimikrobiyal tedavi ve altta yatan komorbiditelerin yönetimine bağlıdır. Intraoperative aspiration is a critical condition characterized by the entry of gastric contents into the lungs during general anesthesia, occurring in 1 out of every 2000 cases and carrying a high risk of morbidity. Diagnosis is established through signs such as sudden hypoxia, tachycardia, increased airway pressures, or direct visualization of gastric contents. Immediate intervention involves placing the patient in the Trendelenburg position and rapid airway suctioning. Risk factors include obesity, emergency surgery, and non-compliance with preoperative fasting; prevention relies on adhering to ASA fasting guidelines and employing rapid sequence induction (RSI). Aspiration pneumonia, which develops following aspiration, is a pulmonary parenchymal infection caused by oropharyngeal or gastric contents. Treatment involves empirical antibiotic therapy determined by the setting of infection (community or hospital) and the patient's risk factors. Intravenous antibiotic use within the last 90 days is the most significant risk factor for resistant pathogens such as MRSA and Pseudomonas. Severe cases may require intensive care monitoring, lung-protective ventilation, or ECMO support. Prognosis depends on early diagnosis, appropriate antimicrobial therapy, and the management of underlying comorbidities.